AKT1 and colonic neoplasm: According to research by Kim et al. (2019) the RSV‐Forskolin combination boosts cAMP levels, which in turn decreases the viability of the DLD‐1 colon cancer cell line by down‐regulating the Akt/mTOR/Myc axis in conjunction with elevated levels of cAMP.